Literature DB >> 15962213

An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics.

Julia Leimkugel1, Abudulai Adams Forgor, Sébastien Gagneux, Valentin Pflüger, Christian Flierl, Elizabeth Awine, Martin Naegeli, Jean-Pierre Dangy, Tom Smith, Abraham Hodgson, Gerd Pluschke.   

Abstract

BACKGROUND: The Kassena-Nankana District (KND) of northern Ghana lies in the African meningitis belt, where epidemics of bacterial meningitis have been reoccurring every 8-12 years. These epidemics are generally caused by Neisseria meningitidis, an organism that is considered to be uniquely capable of causing meningitis epidemics.
METHODS: We recruited all patients with suspected meningitis in the KND between 1998 and 2003. Cerebrospinal fluid samples were collected and analyzed by standard microbiological techniques. Bacterial isolates were subjected to serotyping, multilocus sequence typing (MLST), and antibiotic-resistance testing.
RESULTS: A continual increase in the incidence of pneumococcal meningitis was observed from 2000 to 2003. This outbreak exhibited strong seasonality, a broad host age range, and clonal dominance, all of which are characteristic of meningococcal meningitis epidemics in the African meningitis belt. The case-fatality rate for pneumococcal meningitis was 44.4%; the majority of pneumococcal isolates were antibiotic sensitive and expressed the serotype 1 capsule. MLST revealed that these isolates belonged to a clonal complex dominated by sequence type (ST) 217 and its 2 single-locus variants, ST303 and ST612.
CONCLUSIONS: The S. pneumoniae ST217 clonal complex represents a hypervirulent lineage with a high propensity to cause meningitis, and our results suggest that this lineage might have the potential to cause an epidemic. Serotype 1 is not included in the currently licensed pediatric heptavalent pneumococcal vaccine. Mass vaccination with a less complex conjugate vaccine that targets hypervirulent serotypes should, therefore, be considered.

Entities:  

Mesh:

Year:  2005        PMID: 15962213     DOI: 10.1086/431151

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  90 in total

1.  Invasive serotype 1 Streptococcus pneumoniae outbreaks in the South Pacific from 2000 to 2007.

Authors:  S Le Hello; M Watson; M Levy; S Marcon; M Brown; J F Yvon; I Missotte; B Garin
Journal:  J Clin Microbiol       Date:  2010-06-09       Impact factor: 5.948

2.  Contribution of serotype and genetic background to virulence of serotype 3 and serogroup 11 pneumococcal isolates.

Authors:  Lauren J McAllister; Abiodun D Ogunniyi; Uwe H Stroeher; Amanda J Leach; James C Paton
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

3.  Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin.

Authors:  Lea-Ann S Kirkham; Johanna M C Jefferies; Alison R Kerr; Yu Jing; Stuart C Clarke; Andrew Smith; Tim J Mitchell
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

4.  Sequetyping: serotyping Streptococcus pneumoniae by a single PCR sequencing strategy.

Authors:  Marcus H Leung; Kevin Bryson; Kathrin Freystatter; Bruno Pichon; Giles Edwards; Bambos M Charalambous; Stephen H Gillespie
Journal:  J Clin Microbiol       Date:  2012-05-02       Impact factor: 5.948

5.  Malaria in a holoendemic area of Burkina Faso: a cross-sectional study.

Authors:  August Stich; Nadja Oster; Inas Z Abdel-Aziz; Gabriele Stieglbauer; Boubacar Coulibaly; Hannes Wickert; Jeremy McLean; Bocar A Kouyaté; Heiko Becher; Michael Lanzer
Journal:  Parasitol Res       Date:  2006-01-14       Impact factor: 2.289

6.  African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults.

Authors:  Bradford D Gessner; Judith E Mueller; Seydou Yaro
Journal:  BMC Infect Dis       Date:  2010-02-10       Impact factor: 3.090

7.  The Variable Region of Pneumococcal Pathogenicity Island 1 Is Responsible for Unusually High Virulence of a Serotype 1 Isolate.

Authors:  Richard M Harvey; Claudia Trappetti; Layla K Mahdi; Hui Wang; Lauren J McAllister; Alexandra Scalvini; Adrienne W Paton; James C Paton
Journal:  Infect Immun       Date:  2016-01-11       Impact factor: 3.441

8.  Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah.

Authors:  Carrie L Byington; Kristina G Hulten; Krow Ampofo; Xiaoming Sheng; Andrew T Pavia; Anne J Blaschke; Melinda Pettigrew; Kent Korgenski; Judy Daly; Edward O Mason
Journal:  J Clin Microbiol       Date:  2009-12-16       Impact factor: 5.948

9.  Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands.

Authors:  Gerwin D Rodenburg; Sabine C de Greeff; Angelique G C S Jansen; Hester E de Melker; Leo M Schouls; Eelko Hak; Lodewijk Spanjaard; Elisabeth A M Sanders; Arie van der Ende
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

10.  An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa.

Authors:  Kedibone M Mothibeli; Mignon du Plessis; Anne von Gottberg; Linda de Gouveia; Peter Adrian; Shabir A Madhi; Keith P Klugman
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.